"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 3 | 2 | 5 |
| 2014 | 4 | 1 | 5 |
| 2015 | 7 | 0 | 7 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 5 | 1 | 6 |
| 2020 | 5 | 1 | 6 |
| 2021 | 5 | 0 | 5 |
| 2022 | 8 | 0 | 8 |
| 2023 | 4 | 0 | 4 |
| 2024 | 7 | 2 | 9 |
| 2025 | 4 | 0 | 4 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
Cancer Screening Rates, Disparities by Immigration Status, and Predictors of Cancer Screening Among Black Women With HIV. J Acquir Immune Defic Syndr. 2026 Jun 01; 101(6):597-603.
-
Characteristics predicting reduced penetrance variants in the high-risk cancer predisposition gene TP53. HGG Adv. 2025 Oct 09; 6(4):100484.
-
Call to action for genetic counseling research in hereditary cancer: Considerations from the evidence-based guidelines development process. J Genet Couns. 2025 Jun; 34(3):e70026.
-
Workforce Recommendations to Address Distress and Burnout in Australian Children's Cancer Nurses. J Pediatr Hematol Oncol Nurs. 2025 Jan-Feb; 42(1-2):25-36.
-
"It was time I could have spent better"-the barriers, enablers, and recommendations for improving access to financial aid when a child has cancer. Support Care Cancer. 2025 Mar 15; 33(4):284.
-
Cancer Nurses' Voices and Recommendations to Address Workforce Challenges: A Qualitative Analysis. Semin Oncol Nurs. 2024 10; 40(5):151722.
-
Accelerated aging and young-onset cancer risk!-are stressors of the PELICan hypothesis the missing link? Chin Clin Oncol. 2024 Aug; 13(4):63.
-
Adopting a systems-thinking approach to optimise dietary and exercise referral practices for cancer survivors. Support Care Cancer. 2024 Jul 10; 32(8):502.
-
Preventing adverse events during paediatric cancer treatment: protocol for a multi-site hybrid randomised controlled trial of catheter lock solutions (the CLOCK trial). BMJ Open. 2024 07 09; 14(7):e085637.
-
89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors. Mol Cancer Ther. 2024 Jun 04; 23(6):890-903.